We tracked 0 UK products containing it.
Sodium benzoate is a preservative used in soft drinks, sauces, dressings, and other acidic packaged foods to slow microbial growth and extend shelf life. Most concern centers on three issues: benzene formation in certain vitamin-C drinks, behavior studies in children, and occasional sensitivity reactions. The evidence does not support a simple "safe" or "dangerous" label: there are real narrower concerns, but the broader panic often goes beyond what human studies have actually shown.
This is the best-documented sodium-benzoate-specific concern. In beverages containing benzoate plus ascorbic or erythorbic acid, benzene can form through degradation reactions, especially with heat and light. FDA survey data published in 2008 found the vast majority of sampled drinks had no detectable benzene or levels below the U.S. drinking-water limit, and products at or above that level were reformulated. That means the issue is real, not internet folklore, but it is also product-specific and appears smaller after reformulation than during the mid-2000s soft-drink scare.
The Southampton studies are why this topic still comes up. Double-blind crossover trials in preschool and school-age children found small adverse effects on parent-rated or aggregate hyperactivity measures when children consumed challenge drinks containing artificial colours plus sodium benzoate. But the evidence has two big limits: some objective clinic measures were weaker or null, and the design does not isolate sodium benzoate from the colours. A careful read is that additive mixtures may affect behavior in some children, while the claim that sodium benzoate alone clearly drives ADHD symptoms is stronger than the evidence.
Challenge studies suggest sodium benzoate can provoke urticaria or angioedema in some susceptible people, which is why allergists still keep it on the list of possible additive triggers. But the size of that group appears small. Older provocation studies found some positive sodium-benzoate challenges in patients with chronic urticaria, while a 2014 clinic series of 100 patients with chronic idiopathic urticaria found no confirmed double-blind reactions to the panel of tested additives and concluded additive sensitivity was rare. So this is a real possibility for a minority, not a common explanation for unexplained skin symptoms.
Respiratory sensitivity is part of the older additive literature, but the human evidence is sparse and not dramatic. In a double-blind challenge study of adults with chronic asthma, only one participant reacted to benzoate, and a tartrazine-benzoate avoidance diet did not improve asthma management overall. That does not rule out rare individual sensitivity, especially in people who already suspect additive reactions, but it does argue against treating sodium benzoate as a broad asthma trigger for the general population.
A small randomized crossover trial in 14 overweight adults tested whether a generally recognized as safe dose of sodium benzoate altered glucose and insulin handling during an oral glucose challenge. It did not find a statistically significant adverse acute effect on glucose homeostasis, although it did detect expected shifts in benzoate-related metabolites. That is useful because it pushes back on stronger online claims that sodium benzoate is clearly diabetogenic in humans. But it is still only one small short-term study, so it does not settle questions about chronic exposure.
Much of the more alarming sodium-benzoate content online comes from cell, gene-expression, or animal studies rather than clear human disease data. Those studies do raise hypotheses worth following, including oxidative-stress, inflammatory, and genotoxicity-related signals under some experimental conditions. The problem is translation: doses, exposure routes, and model systems often differ a lot from normal dietary intake. At the moment there is not strong high-quality human evidence showing that ordinary food-level sodium benzoate exposure clearly causes chronic disease, cancer, or neurologic harm on its own.
This is the context claim most people need. Sodium benzoate often shows up in foods with very different health profiles: a little salad dressing, a low-calorie mixer, or a large sugar-sweetened soda. If someone drinks several soft drinks a day, the clearest cardiometabolic issue is usually the drink pattern itself - sugar load, liquid calories, and overall diet quality - while sodium benzoate concerns are narrower and more product-specific. In LP terms: it is reasonable to know about sodium benzoate, but it is rarely the main driver of dietary risk compared with the rest of the eating pattern.
This is editorial summary, not medical advice. Sodium benzoate has a few legitimate caution flags, but most of the broad-brush panic around it goes beyond what the human evidence currently supports.Last hand-reviewed: 2026-05-01